Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma

被引：0
|
作者：
Taku Naiki
Noriyasu Kawai
Yoshihiro Hashimoto
Takehiko Okamura
Ryosuke Ando
Takahiro Yasui
Atsushi Okada
Toshiki Etani
Keiichi Tozawa
Kenjiro Kohri
机构：
[1] Nagoya City University,Department of Nephro
[2] Anjo Kosei Hospital,urology, Graduate School of Medical Sciences
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Metastasis; Urothelial carcinoma; Second-line chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：516 / 522
页数：6
相关论文
共 50 条
  • [31] Pacritaxel as a second-line chemotherapy after failure of gemcitabine
    Egawa, Shinichi
    Motoi, Fuyuhiko
    Maeda, Shinpei
    Kitamura, Yo
    Ariake, Kyouhei
    Kawaguchi, Kei
    Tsukamoto, Hidekazu
    Yokoyama, Satoru
    Aoki, Takeshi
    Ottomo, Shigeru
    Sakata, Naoaki
    Okada, Takaho
    Fukuyama, Shoji
    Rikiyama, Toshiki
    Katayose, Yu
    Unno, Michiaki
    PANCREAS, 2008, 36 (02) : 222 - 222
  • [32] Gemcitabine and cisplatin: Second-line chemotherapy for malignant mesothelioma?
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2626 - 2627
  • [33] The effects of paclitaxel and carboplatin as a second-line chemotherapy against advanced urothelial carcinoma after failure of first-line gemcitabine and cisplatin therapy
    Terakawa, Tomoaki
    Fujisawa, Masato
    Inoue, Takaaki
    Nakano, Yuzo
    Hinata, Nobuyuki
    Harada, Kenichi
    Furukawa, Junya
    Nishikawa, Masayuki
    Miyazaki, Akira
    Imai, Satoshi
    Momozono, Hiroyuki
    INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 : 40 - 40
  • [34] Re: Second-Line Chemotherapy in Older Patients with Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-Line Studies Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 591 - 592
  • [35] Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
    Bellmunt, J.
    de Wit, R.
    Vaughn, D. J.
    Fradet, Y.
    Lee, J. -L.
    Fong, L.
    Vogelzang, N. J.
    Climent, M. A.
    Petrylak, D. P.
    Choueiri, T. K.
    Necchi, A.
    Gerritsen, W.
    Gurney, H.
    Quinn, D. I.
    Culine, S.
    Sternberg, C. N.
    Mai, Y.
    Poehlein, C. H.
    Perini, R. F.
    Bajorin, D. F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11): : 1015 - 1026
  • [36] Pembrolizumab as second-line therapy for advanced urothelial carcinoma
    Douchet, G.
    ONCOLOGIE, 2017, 19 (5-6) : 205 - 206
  • [37] Gemcitabine and cisplatin:: Second-line chemotherapy for malignant mesothelioma?: In reply
    Byrne, MJ
    Dewar, J
    van Hazel, G
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2627 - 2627
  • [38] The Efficacy of Second-line Chemotherapy for Advanced or Metastatic Urothelial Cancer
    Naito, Renato
    Izumi, Kouji
    Kadomoto, Suguru
    Makino, Tomoyuki
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Shigehara, Kazuyoshi
    Kadono, Yoshifumi
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1141 - 1146
  • [39] Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer
    Laack, E
    Dierlamm, T
    Knuffmann, C
    Popp, J
    Schmied, B
    Dürk, H
    Wacker-Backerhaus, G
    Zeller, W
    Verpoort, K
    Fiedler, W
    Hossfeld, DK
    LUNG CANCER, 2002, 36 (03) : 303 - 307
  • [40] Second-line chemotherapy with combined docetaxel and cisplatin for patients with far advanced gastric carcinoma.
    Kunisaki, C
    Akiyama, H
    Otsuka, Y
    Matsuda, G
    Nomura, M
    Hatori, S
    Imada, T
    Togo, S
    Ike, H
    Shimada, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 366S - 366S
12345